There is now strong evidence that metabolic changes associated with cancer, such as mitochondrial dysfunction and increased glycolysis, efficiently promote EMT activation (6), which is in agreement with the notion that PGC-1α antagonizes EMT. The gene discussed is PPARGC1A; the disease is cancer.